Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices

Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools, and Devices provides an in-depth overview of functionalized nanomaterials for cancer research, including treatment, future developments, and their impact on patient outcomes. The book discusses cancer detection and imaging, interactions between nanomaterials and cancer cells, and drug-resistant malignancies. It is a valuable resource for researchers, oncologists, students, and members of the biomedical and medical fields.

Format: Paperback / softback
Length: 500 pages
Publication date: 26 February 2024
Publisher: Elsevier Science Publishing Co Inc

Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools, and Devices is a comprehensive and detailed exploration of the latest knowledge on functionalized nanomaterials in cancer research, encompassing treatment approaches, future developments, and their profound impact on patient outcomes. The book delves into the utilization of functionalized nanoplatforms for cancer detection and imaging, the intricate interactions between nanomaterials and cancer cells, and the challenges posed by drug-resistant malignancies. The chapters in this book are meticulously organized to serve as valuable sources for future studies, highlighting significant in vitro and in vivo nano-therapeutic achievements in cancer treatment. Furthermore, the book discusses current trends in functionalized nanomaterials for cancer research and explores the potential for commercialization in the biomedical and medical fields. This invaluable resource is designed to educate researchers, oncologists, students, and professionals interested in advancing their understanding of the remarkable potential of nanotechnology in cancer research and treatment.
Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools, and Devices is a comprehensive and detailed exploration of the latest knowledge on functionalized nanomaterials in cancer research, encompassing treatment approaches, future developments, and their profound impact on patient outcomes. The book delves into the utilization of functionalized nanoplatforms for cancer detection and imaging, the intricate interactions between nanomaterials and cancer cells, and the challenges posed by drug-resistant malignancies. The chapters in this book are meticulously organized to serve as valuable sources for future studies, highlighting significant in vitro and in vivo nano-therapeutic achievements in cancer treatment. Furthermore, the book discusses current trends in functionalized nanomaterials for cancer research and explores the potential for commercialization in the biomedical and medical fields. This invaluable resource is designed to educate researchers, oncologists, students, and professionals interested in advancing their understanding of the remarkable potential of nanotechnology in cancer research and treatment.

The utilization of functionalized nanoplatforms for cancer detection and imaging has emerged as a promising approach in the field of oncology. These platforms, designed with specific characteristics and functionalities, offer enhanced capabilities for early detection, accurate diagnosis, and personalized treatment of cancer. By leveraging the unique properties of nanomaterials, such as their small size, large surface area, and unique chemical composition, researchers have been able to develop innovative tools and techniques that can detect cancer cells with high sensitivity and specificity.

One of the key applications of functionalized nanomaterials in cancer detection is the development of imaging agents. These agents, such as quantum dots, magnetic resonance imaging (MRI), and positron emission tomography (PET), can be conjugated with specific cancer-targeting molecules or antibodies to enhance their imaging properties. For example, quantum dots have been used to label cancer cells, allowing for more precise and accurate imaging of tumor sites. MRI can be used to detect tumors at an early stage by using contrast agents that bind to cancer cells, while PET can be used to detect metabolic changes associated with cancer cells.

In addition to cancer detection, functionalized nanomaterials are also being used in cancer imaging to provide more detailed information about the tumor and its surrounding environment. For instance, magnetic resonance elastography (MRE) is a technique that uses magnetic fields to measure the mechanical properties of tissues, including tumors. This information can help physicians identify tumor characteristics, such as size, shape, and stiffness, which can aid in treatment planning and monitoring.

Another important application of functionalized nanomaterials in cancer research is the development of drug delivery systems. These systems are designed to deliver therapeutic agents directly to cancer cells, minimizing the exposure of healthy tissues to harmful drugs. One of the most promising drug delivery systems is nanoparticle-based drug delivery systems, which are composed of small particles that can be engineered to target specific cancer cells while sparing healthy cells. Nanoparticle-based drug delivery systems have been shown to improve the efficacy of chemotherapy and radiation therapy by targeting cancer cells while minimizing side effects.

Furthermore, functionalized nanomaterials are being explored for their potential to enhance cancer therapy by targeting specific cancer cells or signaling pathways. For example, nanomaterials can be used to deliver therapeutic agents directly to cancer cells, such as chemotherapy drugs or gene therapy vectors. Nanomaterials can also be used to enhance the immune response against cancer cells, such as by delivering immune-stimulating agents or vaccines.

Despite the promising applications of functionalized nanomaterials in cancer research, there are also concerns about their safety and efficacy. One of the main concerns is the potential for nanomaterials to cause unintended side effects, such as inflammation or toxicity. Additionally, there is a need for more research to determine the long-term effects of exposure to functionalized nanomaterials on human health.

To address these concerns, researchers are actively developing new and improved functionalized nanomaterials that are safer and more effective. For example, researchers are exploring the use of biodegradable nanomaterials, which are designed to break down naturally in the body over time, reducing the risk of long-term side effects. Additionally, researchers are developing nanomaterials that are more targeted and specific to cancer cells, reducing the risk of unintended effects on healthy cells.

In conclusion, functionalized nanomaterials have emerged as a promising tool in cancer research, offering enhanced capabilities for cancer detection, imaging, and therapy. By leveraging the unique properties of nanomaterials, researchers have been able to develop innovative tools and techniques that can improve the accuracy and effectiveness of cancer treatment. However, there is still a need for more research to determine the safety and efficacy of these materials and to develop new and improved functionalized nanomaterials that are safer and more effective.

Dimension: 235 x 191 (mm)
ISBN-13: 9780443155185